Related Experiment Video
Updated: May 6, 2026

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
Published on: May 21, 2017
Long-Term Outcomes After Transcatheter Aortic Valve Implantation in Patients With Chronic Inflammatory Disease
Stephanie Brunner1, Olga Covtun1, Federico Moccetti1
1Heart Center Lucerne, Cardiology Division, Luzerner Kantonsspital Lucerne Switzerland.
Insights
Patients with chronic inflammatory disease (CID) undergoing transcatheter aortic valve implantation (TAVI) face increased infection risks but show similar survival and valve durability compared to those without CID.
Area of Science:
- Cardiology
- Rheumatology
- Infectious Diseases
Background:
- Chronic inflammatory disease (CID) is linked to accelerated atherosclerosis and aortic stenosis.
- Long-term outcomes after transcatheter aortic valve implantation (TAVI) in CID patients are not well-documented.
Purpose of the Study:
- To investigate the clinical long-term outcomes of patients with and without autoimmune-related CID undergoing TAVI for severe aortic stenosis.
Main Methods:
- Prospective registry analysis of 1000 consecutive TAVI patients.
- Assessment of baseline and long-term (up to 5 years) clinical and echocardiographic outcomes.
- Comparison of outcomes between patients with and without CID, including specific inflammatory conditions.
Main Results:
- 11% of TAVI patients had CID (e.g., polymyalgia rheumatica, rheumatoid arthritis).
- CID patients were more often female and had higher rates of pulmonary disorders and atrial fibrillation.
- CID was associated with increased post-TAVI infection rates and rehospitalization for bleeding or infection.
Conclusions:
- TAVI in CID patients is linked to a higher risk of post-procedural infectious complications and infection-related rehospitalization.
- Valve durability and overall survival appear unaffected by the presence of CID post-TAVI.
Background:
Chronic inflammatory disease (CID) accelerates atherosclerosis and the development of aortic stenosis. Data on long-term outcomes after transcatheter aortic valve implantation (TAVI) in those patients are missing. The aim of this study was to investigate the clinical long-term outcomes of patients with and without autoimmune-related CID undergoing TAVI for the treatment of severe aortic stenosis.
Methods And Results:
From a prospective registry, consecutive patients with TAVI were included. Baseline clinic and imaging data (echocardiographic and computed tomography) were analyzed. Long-term (up to 5 years) clinical and echocardiographic outcomes were studied. Of 1000 consecutive patients (mean age 81±6 years, 46% female), 107 (11%) had CID; the most frequent entities included polymyalgia rheumatica (31%) and rheumatoid arthritis (28%). Patients with CID were predominantly female (60% versus 44%, P=0.002) and more often had pulmonary disorders (21% versus 13%, P=0.046) and atrial fibrillation (32% versus 20%, P=0.003). The presence of CID was associated with a higher rate of postinterventional infection (5% versus 1%, P=0.007) and further emerged as a risk factor for rehospitalization for bleeding or infection (hazard ratio, 1.93 and 1.62, respectively). Premature valve degeneration, endocarditis, and all-cause mortality were not increased among patients with CID.
Conclusions:
This real-world analysis found that patients with CID undergoing TAVI were associated with a higher risk of postinterventional infectious complications and rehospitalization due to infection. However, valve durability and survival seem not to differ between patients with TAVI with versus without CID.
More Related Videos
14:14Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
Published on: December 11, 2017
04:30Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
Published on: February 4, 2021
Related Concept Videos
Mitral Stenosis III: Medical Management
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic Regurgitation III: Medical Management
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Chronic Inflammation: Introduction